TAT-MafA Protein Enhances Insulin Production in Developing Pancreas
Author Information
Author(s): Vargas Nancy, Álvarez-Cubela Silvia, Giraldo Jaime A., Nieto Margarita, Fort Nicholas M., Cechin Sirlene, García Enrique, Espino-Grosso Pedro, Fraker Christopher A., Ricordi Camillo, Inverardi Luca, Pastori Ricardo L., Domínguez-Bendala Juan
Primary Institution: Diabetes Research Institute, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, United States of America
Hypothesis
Does TAT-MafA protein injected in utero enhance pancreatic insulin expression and islet morphology?
Conclusion
Injecting TAT-MafA in utero significantly increases insulin production and improves islet structure in developing mouse embryos.
Supporting Evidence
- TAT-MafA significantly up-regulates target genes related to insulin production.
- Islet morphology improved in TAT-MafA treated embryos compared to controls.
- Insulin levels in the pancreata of TAT-MafA treated embryos doubled compared to controls.
- Immunofluorescence showed more organized islets in TAT-MafA treated embryos.
Takeaway
Scientists found that giving a special protein called TAT-MafA to baby mice while they were still in their mom's belly helped their bodies make more insulin and grow better pancreas cells.
Methodology
The study involved injecting TAT-MafA protein into the hearts of developing mouse embryos and analyzing the resulting pancreatic development and insulin expression.
Potential Biases
Potential off-target effects due to the systemic delivery of the protein.
Limitations
The study primarily focused on mouse models, which may not fully replicate human biology.
Participant Demographics
C57BL/6 mice were used for all animal experiments.
Statistical Information
P-Value
0.0009
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website